Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs IMATINIB: Safety Overview

Metric DASATINIB IMATINIB
Total FAERS Reports 30,019 43,161
Deaths Reported 2,681 13,761
Death Rate 8.9% 31.9%
Hospitalizations 6,437 7,264
Average Patient Age 56.4 yrs 55.7 yrs
% Female Patients 51.9% 47.2%
FDA Approval Date Apr 22, 2025 Apr 14, 2025
Manufacturer Zydus Pharmaceuticals USA Inc. Dr.Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Discontinued